Buscar
Congreso SOLACI

Búsqueda de: stent

Si no está conforme con los resultados, inténtelo de nuevamente.
Coronary disease

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous...
Dr. Andrés Rodríguez -
Ir
Chronic Coronary Syndromes

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases...
Dr. Omar Tupayachi -
Ir
Coronary disease

TCT 2025 | INFINITY–SWEDEHEART: Long-Term Outcomes of the Bioadaptive Coronary Implant Versus Drug-Eluting Stent

The bioadaptive coronary implant DynamX (Elixir Medical, California) was developed to restore normal vascular function after angioplasty,...
Dr. Juan Manuel Pérez -
Ir
Coronary disease

TCT 2025 | REC-CAGEFREE I: Three-Year Follow-Up of Drug-Coated Balloon Angioplasty vs Stent in De Novo Coronary Lesions

The REC-CAGEFREE I trial evaluated the safety and efficacy of paclitaxel-coated balloon (DCB) angioplasty versus sirolimus-eluting stent...
Dr. Juan Manuel Pérez -
Ir
Coronary disease

TCT 2025 | IRONMAN II Study: Sirolimus-Eluting Iron Bioresorbable Stent in Coronary Artery Disease

Bioresorbable coronary stents represent a step toward strategies without permanent metallic implants, although the first polymer-based platforms...
Dr. Juan Manuel Pérez -
Ir
Institutional News

SOL SOLACI performed a new procedure in Argentina using bioabsorbable stents in pulmonary branches

The SOLACI Solidarity Program carried out a new procedure on a patient from the region of Frías,...
solaci -
Ir
Acute coronary syndromes

TCT 2025 | SELUTION4ISR: sirolimus-eluting balloon for in-stent restenosis

In-stent restenosis (ISR) continues to be a relevant clinical challenge in contemporary PCI practice. In the DES...
Dr. Omar Tupayachi -
Ir
Acute coronary syndromes

TCT 2025 | SELUTION DeNovo: sirolimus-eluting balloon vs. stent in de novo coronary lesions

The use of drug-eluting stents (DES) remains the standard strategy in most percutaneous coronary intervention (PCI) procedures....
Dr. Omar Tupayachi -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

Dr. Omar Tupayachi - 0
The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Dr. Andrés Rodríguez - 0
Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Dr. Juan Manuel Pérez - 0
Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad